울트라제닉스 파마슈티컬 (RARE)

12:43 PM

Ultragenyx outlines 14%–20% 2025 revenue growth, advances late-stage pipeline with $400M OMERS financing - MSN

12:43 PM

12:35 PM

Ultragenyx Pharmaceutical Inc (RARE) Q3 2025 Earnings Call Highl - GuruFocus

12:35 PM

Nov 04, 2025

Ultragenyx Reports Q3 2025 Financial Results - TipRanks

Nov 04, 2025

Nov 04, 2025

Ultragenyx Reports Growth And Wall Street Sees More Ahead - Finimize

Nov 04, 2025

Nov 04, 2025

Ultragenyx (RARE) Secures $400M Through Expanded Royalty Deal wi - GuruFocus

Nov 04, 2025

Nov 04, 2025

Ultragenyx tumbles on $400 mln Crysvita royalty sale - TradingView

Nov 04, 2025

Nov 04, 2025

Here's What Key Metrics Tell Us About Ultragenyx (RARE) Q3 Earnings - Nasdaq

Nov 04, 2025

Nov 04, 2025

Ultragenyx shares tumble as third quarter earnings fall short of expectations - Investing.com UK

Nov 04, 2025

Nov 04, 2025

Ultragenyx (RARE) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 04, 2025

Nov 04, 2025

Ultragenyx sells some royalties on Crysvita to OMERS Life Sciences - Seeking Alpha

Nov 04, 2025

Nov 04, 2025

Ultragenyx (RARE) Maintains 2025 Financial Guidance and Projects Profitability in 2027 - GuruFocus

Nov 04, 2025

Nov 04, 2025

Ultragenyx Pharmaceutical Inc Reports Q3 2025 Earnings: EPS of - GuruFocus

Nov 04, 2025

Nov 04, 2025

RARE's Q3 Revenue Misses Estimates Amid Strategic Advancements - GuruFocus

Nov 04, 2025

Nov 04, 2025

Ultragenyx Signs $400M Royalty Purchase Agreement - TipRanks

Nov 04, 2025

Nov 04, 2025

Ultragenyx: Q3 Earnings Snapshot - News-Times

Nov 04, 2025

Nov 04, 2025

Ultragenyx Reports Third Quarter 2025 Financial Results and Corporate Update - The Manila Times

Nov 04, 2025

Nov 04, 2025

Ultragenyx (NASDAQ: RARE) sells Crysvita royalties to OMERS for $400M, capped at 1.55x - Stock Titan

Nov 04, 2025

Nov 04, 2025

Published on: 2025-11-04 05:38:55 - newser.com

Nov 04, 2025

Nov 04, 2025

Is Ultragenyx Pharmaceutical Inc. stock attractive for long term wealth buildingQuarterly Earnings Summary & Weekly Watchlist for Hot Stocks - newser.com

Nov 04, 2025

Nov 04, 2025

Will Ultragenyx Pharmaceutical Inc. (UP0) stock hit Wall Street targetsJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

Can Ultragenyx Pharmaceutical Inc. rally from current levelsM&A Rumor & Safe Entry Trade Reports - newser.com

Nov 04, 2025

Nov 04, 2025

Is it too late to sell Ultragenyx Pharmaceutical Inc.IPO Watch & Community Verified Trade Signals - newser.com

Nov 04, 2025

Nov 04, 2025

Published on: 2025-11-04 02:37:03 - newser.com

Nov 04, 2025

Nov 04, 2025

Published on: 2025-11-04 01:40:43 - newser.com

Nov 04, 2025

Nov 04, 2025

Is Ultragenyx Pharmaceutical Inc. stock dividend yield sustainableStock Surge & AI Based Buy and Sell Signals - newser.com

Nov 04, 2025

Nov 04, 2025

Will Ultragenyx Pharmaceutical Inc. stock remain a Wall Street favorite - newser.com

Nov 04, 2025

Nov 03, 2025

What hedge fund moves indicate for Ultragenyx Pharmaceutical Inc. (UP0) stockRate Cut & Weekly Breakout Watchlists - newser.com

Nov 03, 2025

Nov 03, 2025

Dosing begins in broader trial of Angelman syndrome therapy - Angelman Syndrome News

Nov 03, 2025

Nov 03, 2025

Key metrics from Ultragenyx Pharmaceutical Inc.’s quarterly data2025 Market Overview & Technical Pattern Based Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Why Ultragenyx Pharmaceutical Inc. stock appeals to dividend seekersJuly 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Earnings visualization tools for Ultragenyx Pharmaceutical Inc.2025 Support & Resistance & Weekly Momentum Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Can Ultragenyx Pharmaceutical Inc. (UP0) stock surprise with quarterly results2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Can Ultragenyx Pharmaceutical Inc. (UP0) stock hold up in economic slowdownQuarterly Performance Summary & Daily Volume Surge Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Is this a good reentry point in Ultragenyx Pharmaceutical Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Is Ultragenyx Pharmaceutical Inc. stock a buy in volatile marketsAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Pinnacle Associates Ltd. Sells 29,107 Shares of Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 03, 2025

Nov 03, 2025

Chart based analysis of Ultragenyx Pharmaceutical Inc. trends - newser.com

Nov 03, 2025

Nov 03, 2025

Is Ultragenyx Pharmaceutical Inc. still worth holding after the dipTrade Volume Summary & Verified Chart Pattern Trade Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Is Ultragenyx Pharmaceutical Inc. stock a top momentum playTrade Entry Summary & High Yield Equity Trading Tips - newser.com

Nov 03, 2025

Nov 02, 2025

Can Ultragenyx Pharmaceutical Inc. stock sustain revenue growthJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com

Nov 02, 2025

Nov 02, 2025

How risky is Ultragenyx Pharmaceutical Inc. stock nowJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com

Nov 02, 2025

Nov 02, 2025

Can Ultragenyx Pharmaceutical Inc. stock deliver sustainable ROEJuly 2025 Short Interest & Long-Term Growth Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Is Ultragenyx Pharmaceutical Inc. stock attractive after correctionWatch List & Long Hold Capital Preservation Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Y Intercept Hong Kong Ltd Grows Stake in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat

Nov 02, 2025

Nov 01, 2025

Will Ultragenyx Pharmaceutical Inc. see short term momentum2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com

Nov 01, 2025

Nov 01, 2025

Will Ultragenyx Pharmaceutical Inc. stock benefit from upcoming earnings reports2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com

Nov 01, 2025